Compare Stocks: MTR, AFRK, KOD, and HUM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HUM Humana	$373.54 +0.4%	$386.70	$163.11 ▼ $428.88	$44.67B	0.74	878,613 shs	798,579 shs
KOD Kodiak Sciences	$31.52 -6.7%	$38.67	$10.94 ▼ $47.84	$2.12B	2.18	665,558 shs	1.05 million shs
MTR Mesa Royalty Trust	$2.40 -1.2%	$2.69	$2.17 ▼ $5.83	$4.53M	0.41	13,672 shs	4,293 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HUM Humana	+0.43%	-2.84%	-3.33%	-0.51%	+44.81%
KOD Kodiak Sciences	-6.75%	-3.81%	-15.31%	-7.54%	+129.74%
MTR Mesa Royalty Trust	-1.44%	-2.04%	-8.19%	-23.57%	-57.17%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HUM Humana	$373.54 +0.4%	$386.70	$163.11 ▼ $428.88	$44.67B	0.74	878,613 shs	798,579 shs
KOD Kodiak Sciences	$31.52 -6.7%	$38.67	$10.94 ▼ $47.84	$2.12B	2.18	665,558 shs	1.05 million shs
MTR Mesa Royalty Trust	$2.40 -1.2%	$2.69	$2.17 ▼ $5.83	$4.53M	0.41	13,672 shs	4,293 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HUM Humana	+0.43%	-2.84%	-3.33%	-0.51%	+44.81%
KOD Kodiak Sciences	-6.75%	-3.81%	-15.31%	-7.54%	+129.74%
MTR Mesa Royalty Trust	-1.44%	-2.04%	-8.19%	-23.57%	-57.17%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HUM Humana	2.43	Hold	$403.91	8.13% Upside
KOD Kodiak Sciences	2.57	Moderate Buy	$53.67	70.26% Upside
MTR Mesa Royalty Trust	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest MTR, AFRK, KOD, and HUM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/24/2026	KOD Kodiak Sciences	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$36.00
9/17/2026	KOD Kodiak Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$58.00
9/4/2026	HUM Humana	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
8/24/2026	HUM Humana	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$450.00
8/21/2026	MTR Mesa Royalty Trust	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/17/2026	KOD Kodiak Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$58.00
8/14/2026	HUM Humana	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/11/2026	HUM Humana	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/10/2026	HUM Humana	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$316.00 ➝ $393.00
8/7/2026	MTR Mesa Royalty Trust	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/4/2026	HUM Humana	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$249.00 ➝ $370.00

(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HUM Humana	$129.66B	0.35	$24.16 per share	15.46	$147.47 per share	2.53
KOD Kodiak Sciences	N/A	N/A	N/A	N/A	$2.97 per share	N/A
MTR Mesa Royalty Trust	$476.74K	9.38	$0.23 per share	10.43	$1.70 per share	1.41

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HUM Humana	$1.19B	$10.57	35.34	24.32	2.30	0.88%	11.20%	3.94%	11/6/2026 (Estimated)
KOD Kodiak Sciences	-$229.97M	-$4.19	N/A	N/A	N/A	N/A	-273.23%	-85.48%	11/12/2026 (Estimated)
MTR Mesa Royalty Trust	$510K	$0.16	15.00	N/A	N/A	60.59%	9.17%	8.82%	N/A

Latest MTR, AFRK, KOD, and HUM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	MTR Mesa Royalty Trust	N/A	$0.07	N/A	$0.07	N/A	$0.16 million
8/12/2026	Q2 2026	KOD Kodiak Sciences	-$0.9565	-$1.05	-$0.0935	-$1.05	N/A	N/A
7/29/2026	Q2 2026	HUM Humana	$7.27	$7.61	+$0.34	$5.73	$40.58 billion	$40.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HUM Humana	$3.54	0.95%	+7.20%	33.49%	N/A
KOD Kodiak Sciences	N/A	N/A	N/A	N/A	N/A
MTR Mesa Royalty Trust	$0.29	12.08%	-4.53%	181.25%	1 Years

Latest MTR, AFRK, KOD, and HUM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
9/1/2026	HUM Humana	quarterly	$0.8850	0.88%	10/30/2026	10/30/2026	11/27/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HUM Humana	0.62	1.74	1.74
KOD Kodiak Sciences	N/A	2.49	2.49
MTR Mesa Royalty Trust	N/A	17.13	17.13

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HUM Humana	92.38%
KOD Kodiak Sciences	89.06%
MTR Mesa Royalty Trust	12.73%

Insider Ownership

Company	Insider Ownership
HUM Humana	0.20%
KOD Kodiak Sciences	44.40%
MTR Mesa Royalty Trust	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HUM Humana	67,060	120.08 million	119.84 million	Optionable
KOD Kodiak Sciences	124	62.85 million	34.94 million	Optionable
MTR Mesa Royalty Trust	N/A	1.86 million	N/A	Not Optionable

MTR, AFRK, KOD, and HUM Headlines

Recent News About These Companies

Mesa Royalty Trust stock holds near its latest trading level

September 23 at 2:37 AM | ad-hoc-news.deA

Mesa Royalty Trust stock holds steady on thin trading

September 21 at 11:02 PM | ad-hoc-news.deA

Mesa Royalty Trust Announces There Will Be No Distribution for September 2026

September 18, 2026 | businesswire.com

Mesa Royalty Trust Announces There Will Be No Distribution for August 2026

August 21, 2026 | businesswire.com

Mesa Royalty Trust Units of Benef Interest

August 5, 2026 | markets.businessinsider.com

Mesa Royalty Trust says no distribution for July

July 20, 2026 | seekingalpha.com

Mesa Royalty Trust Announces There Will Be No Distribution for July 2026

July 20, 2026 | businesswire.com

Mesa Royalty Trust

June 24, 2026 | cnn.com

Mesa Royalty Trust Announces There Will Be No Distribution for June 2026

June 18, 2026 | businesswire.com

Mesa Royalty Trust Announces Trust Income for May 2026

May 18, 2026 | businesswire.com

Mesa Royalty Trust declares $0.0402 dividend

April 20, 2026 | seekingalpha.com

Mesa Royalty Trust Announces Trust Income for April 2026

April 17, 2026 | businesswire.com

Why Mesa Royalty Trust’s (MTR) 2025 Distribution Rose Despite Lower Royalty Income

April 7, 2026 | insidermonkey.com

Mesa Royalty Trust - Units of Beneficial Interest

April 2, 2026 | money.usnews.com

Mesa Royalty Trust Announces Trust Income for March 2026

March 20, 2026 | businesswire.com

MTR Corporation Limited (MTCPY) Q4 2025 Earnings Call Prepared Remarks Transcript

March 16, 2026 | seekingalpha.com

Mesa Royalty Trust Announces There Will Be No Distribution for February 2026

February 17, 2026 | businesswire.com

Mesa Royalty Trust Announces Trust Income for January 2026

January 20, 2026 | finance.yahoo.com

Mesa Royalty Trust Announces Trust Income for January 2026

January 20, 2026 | businesswire.com

Mesa Royalty Trust declares $0.0186 dividend

December 19, 2025 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MTR, AFRK, KOD, and HUM Company Descriptions

Humana NYSE:HUM

$373.54 +1.54 (+0.41%)

Closing price 09/23/2026 03:59 PM Eastern

Extended Trading

$373.15 -0.39 (-0.11%)

As of 07:44 AM Eastern

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Kodiak Sciences NASDAQ:KOD

$31.52 -2.28 (-6.75%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$31.52 +0.00 (+0.01%)

As of 07:20 AM Eastern

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Mesa Royalty Trust NYSE:MTR

$2.40 -0.03 (-1.23%)

Closing price 09/23/2026 03:57 PM Eastern

Extended Trading

$2.45 +0.05 (+2.04%)

As of 07:02 AM Eastern

Mesa Royalty Trust owns overriding royalty interests in various oil and gas producing properties in the United States. It holds interests in properties located in the Hugoton field of Kansas; and the San Juan Basin field of Northwestern New Mexico and Southwestern Colorado. The company was founded in 1979 and is based in Houston, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MTR, AFRK, KOD, and HUM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MTR, AFRK, KOD, and HUM Earnings

Compare Dividends

Latest MTR, AFRK, KOD, and HUM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MTR, AFRK, KOD, and HUM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MTR, AFRK, KOD, and HUM Company Descriptions

Humana NYSE:HUM

Kodiak Sciences NASDAQ:KOD

Mesa Royalty Trust NYSE:MTR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MTR, AFRK, KOD, and HUM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MTR, AFRK, KOD, and HUM Earnings

Compare Dividends

Latest MTR, AFRK, KOD, and HUM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MTR, AFRK, KOD, and HUM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MTR, AFRK, KOD, and HUM Company Descriptions

Humana NYSE:HUM

Kodiak Sciences NASDAQ:KOD

Mesa Royalty Trust NYSE:MTR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools